Development & Commercialization
The CTSC can help move your ideas and inventions into development and commercialization.
We educate through special training seminars and consultation on how to commercialize your discoveries. We also provide information on the latest news in technology transfer so you can learn what it takes to get SBIR/STTR awards or other funding, stay up-to-date on regulations and find out what others are doing with technology transfer. We help you identify research and development partners and opportunities for collaboration through meetings, presentations and forums. We support tech transfer through pilot funding and consultations on institutional and federal regulatory and compliance processes. And finally, we enable – we will help you pursue SBIR/STTR funding, navigate institutional requirements and connect with partners for help with intellectual property disclosure and patent submission and to find, or create, a start-up company to pursue other local sources of funding.
Office of Research SBIR/STTR Information Portal
The HSC Office of Research has compiled information for more information and links to external resources on how SBIR/STTR funding opportunities. Please visit the SBIR/STTR Information Portal.
HSC Research Policies and Guidelines
CTSC regulatory experts are available to assist you in navigating HSC Research Policies and Guidelines, or will be able to help connect you to the right office at HSC for any questions you may have.
Federal Regulatory Support
The CTSC’s Regulatory Support Unit offers many resources for navigating federal regulatory processes, including online Investigational New Drug (IND) and Investigational Device Exemption (IDE) training and IND/IDE personalized consultation. Please contact Sherry Sazesh, Regulatory Affairs Manager, for more information.
Synergy Meetings bring together basic, clinical, and community-engaged researchers from many disciplines to advance translational projects from bench to bedside. These monthly meetings are an opportunity to learn more about ongoing studies, clinical and translational methods, resources available through the CTSC, and opportunities for collaboration. Each meeting is focused on a specific topic and includes presentations from invited speakers.
The CTSC Biodesign Initiative brings together biomedical researchers, clinicians, engineers, and other specialists to develop commercially viable medical devices that will greatly impact the everyday lives of people living with diseases and health conditions. During facilitated brainstorming sessions, participants devise solutions to existing barriers and problems in current clinical practices. Successful teams are encouraged to submit a proposal for CTSC pilot funding, which provides access and financial support to use CTSC’s translational technologies and clinical facilities.
The CTSC offers New Technology and Commercialization pilot awards twice yearly.
The purpose of this RFA is to support innovative, high-risk/high-reward pilot projects to produce preliminary data for competitive NIH proposals and for the development of new technology and corporate relationships to move a project toward successful commercialization. Most awards will be expected to see NIH funding through an SBIR/STTR mechanism. Technologies should help to fulfill the CTSC mission of developing novel approaches to translational research and promote and support the "bench to bedside to community and practice and back" goal of the NIH.
CTSC Regulatory Support Unit
The CTSC’s Regulatory Support Unit offers a range of support to meet institutional processes and federal regulations.
CTSC Clinical & Translational Technologies
The CTSC Clinical & Translational Technologies supports commercialization by facilitating interaction between technology experts and translational investigators and providing access to state-of-the-art lab equipment, testing services and specialized assistance for protocol/assay development.
STC.UNM facilitates intellectual property disclosure filing and patent submission for all UNM investigators.
NMBio is a catalyst for bioscience industry acceleration in New Mexico, providing a forum for information exchange, developing initiatives to enhance business success and bioscience education, helping establish collaboration and serving as a voice of the industry to state, federal and local governments.
STC.UNM (formerly known as the Science & Technology Corporation @ UNM) is a 501(c)(3) nonprofit corporation formed and owned entirely by the University of New Mexico Board of Regents (UNM), with an independent board of directors. Its mission is to support the University of New Mexico and its partners as the source for innovation management and commercial development. STC files invention disclosure forms and patents for UNM faculty, staff and students.
Located on UNM's south campus at the Science & Technology Park in Albuquerque, STC has proximity to research and development and laboratory facilities and other technology based companies, many of which are the creation of STC. STC also collaborates with researchers at New Mexico's two national labs, Sandia National Laboratories and Los Alamos National Laboratory.
New Mexico Angels’ mission is to provide opportunities where its members can obtain outstanding financial returns by investing in early-stage companies in New Mexico and the Southwest Region and accelerating them to market leadership. We work with the venture capital community and angel groups in the Southwestern area.